+
1.
Which of the following have led to regulatory concerns about the cardiovascular safety of ADHD medications?
2.
For which of the following outcomes was the risk increased during exposure to methylphenidate?
3.
Which of the following reasons could potentially explain the inverse dose-response relationship and the rates of stroke, myocardial infarction, and all-cause death?